THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NASDAQ:RPRX) and (PCX:RPRX) today announced plans to withdraw the listing of its common stock from NYSE Arca, Inc., formerly the Pacific Exchange. Repros’ common stock will continue to be listed on the NASDAQ Global Market Exchange.